Materials & Resources » Mining, Metals & Minerals | Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$36.3 M
Shares Outstanding
134.46 M
Public Float
43.65 M

Profile

Address
No. 3 Bethesda Metro Center
Bethesda Maryland 20814
United States
Employees -
Website http://www.cannabics.com
Updated 07/08/2019
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

Financials

View All

Eyal Barad
Chief Executive Officer & Director
Eyal Ballan
Director & Chief Technical Officer